Regulation of Involucrin in Psoriatic Epidermal Keratinocytes: The Roles of ERK1/2 and GSK-3β

Cell Biochemistry and Biophysics

Volumn 66, Issue 3, 2013, Pages 523-528

  Chen, Jia Qi ^a   Man, Xiao Yong ^a   Li, Wei ^a   Zhou, Jiong ^a   Landeck, Lilla ^b   Cai, Sui Qing ^a   Zheng, Min ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

ERK1 2; GSK 3 ; Involucrin; Keratinocyte; Psoriasis

Indexed keywords

EID: 84880962949     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9499-y     Document Type: Article

References (27)

1. Nestle, F. O., Kaplan, D. H., & Barker, J. (2009). Psoriasis. New England Journal of Medicine, 361, 496-509.
2. Candi, E., Schmidt, R., & Melino, G. (2005). The cornified envelope: a model of cell death in the skin. Nature Reviews Molecular Cell Biology, 6, 328-340.
3. Bernerd, F., Magnaldo, T., & Darmon, M. (1992). Delayed onset of epidermal differentiation in psoriasis. Journal of Investigative Dermatology, 98, 902-910.
4. Rice, R. H., & Green, H. (1977). The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell, 11, 417-422.
5. Bhargava, G., Rifas, L., & Makman, M. H. (1979). Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells. Journal of Cellular Physiology, 100, 365-374.
6. Bernard, B. A., Robinson, S. M., Vandaele, S., Mansbridge, J. N., & Darmon, M. (1985). Abnormal maturation pathway of keratinocytes in psoriatic skin. British Journal of Dermatology, 112, 647-653.
7. Schroeder, W. T., Thacher, S. M., Stewart-Galetka, S., Annarella, M., Chema, D., Siciliano, M. J., et al. (1992). Type I keratinocyte transglutaminase: expression in human skin and psoriasis. Journal of Investigative Dermatology, 99, 27-34.
8. Eckert, R. L., Sturniolo, M. T., Broome, A. M., Ruse, M., & Rorke, E. A. (2005). Transglutaminase function in epidermis. Journal of Investigative Dermatology, 124, 481-492.
9. Yano, S., Banno, T., Walsh, R., & Blumenberg, M. (2008). Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. Journal of Cellular Physiology, 214, 1-13.
10. Takahashi, H., Asano, K., Nakamura, S., Ishida-Yamamoto, A., & Iizuka, H. (1999). Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity. Biochemical Journals, 344, 797-802.
11. Marble, D. J., Gordon, K. B., & Nickoloff, B. J. (2007). Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. Journal of Dermatological Science, 48, 87-101.
12. Simeone, P., Teson, M., Latini, A., Carducci, M., & Venuti, A. (2004). Endothelin-1 could be one of the targets of psoriasis therapy. British Journal of Dermatology, 151, 1273-1275.
13. Johansen, C., Kragballe, K., Westergaard, M., Henningsen, J., Kristiansen, K., & Iversen, L. (2005). The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. British Journal of Dermatology, 152, 37-42.
14. Bollag, W. B., Zhong, X., Dodd, M. E., Hardy, D. M., Zheng, X., & Allred, W. T. (2005). Phospholipase d signaling and extracellular signal-regulated kinase-1 and -2 phosphorylation (activation) are required for maximal phorbol ester-induced transglutaminase activity, a marker of keratinocyte differentiation. Journal of Pharmacology and Experimental Therapeutics, 312, 1223-1231.
15. Hampton, P. J., Jans, R., Flockhart, R. J., Parker, G., & Reynolds, N. J. (2011). Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2). Journal of Cellular Physiology, 227, 1529-1537.
16. Jang, H. D., Shin, J. H., Park, D. R., Hong, J. H., Yoon, K., Ko, R., et al. (2011). Inactivation of glycogen synthase kinase-3{beta} is required for osteoclast differentiation. Journal of Biological Chemistry, 286, 39043-39050.
17. Man, X. Y., Yang, X. H., Cai, S. Q., Bu, Z. Y., & Zheng, M. (2008). Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. Journal of Cellular and Molecular Medicine, 12, 649-660.
18. Man, X. Y., Yang, X. H., Cai, S. Q., Yao, Y. G., & Zheng, M. (2006). Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Molecular Medicine, 12, 127-136.
19. Ishida-Yamamoto, A., & Iizuka, H. (1995). Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis. Journal of Investigative Dermatology, 104, 391-395.
20. Takahashi, H., Tsuji, H., Hashimoto, Y., Ishida-Yamamoto, A., & Iizuka, H. (2010). Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clinical and Experimental Dermatology, 35, 645-649.
21. Deeva, I., Mariani, S., De Luca, C., Pacifico, V., Leoni, L., Raskovic, D., et al. (2010). Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine, 49, 163-170.
22. Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005). Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of Inflammation, 2005, 273-279.
23. Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B. W., Boutrin, A., et al. (2008). Type I interferon: potential therapeutic target for psoriasis? PLoS One, 3, 2737.
24. van der Fits, L., Mourits, S., Voerman, J. S., Kant, M., Boon, L., Laman, J. D., et al. (2009). Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. Journal of Immunology, 182, 5836-5845.
25. Cancino-Diaz, J. C., Reyes-Maldonado, E., Banuelos-Panuco, C. A., Jimenez-Zamudio, L., Garcia-Latorre, E., Leon-Dorantes, G., et al. (2002). Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. Journal of Investigative Dermatology, 119, 1114-1120.
26. Kim, B. E., Howell, M. D., Guttman, E., Gilleaudeau, P. M., Cardinale, I. R., Boguniewicz, M., et al. (2011). TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. Journal of Investigative Dermatology, 131, 1272-1279.
27. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., et al. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.